NCT01413048View on ClinicalTrials.gov

Clinical Trial to Evaluate the Antihypertensive Effect of AGSCT101 in Patient With Hypertension

PHASE3UnknownINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

September 30, 2012

Conditions
Essential Hypertension
Interventions
DRUG

Carvedilol 25mg

Tablet, q.d.

DRUG

AGSCT101 12.5mg

Tablet, q.d.

Trial Locations (1)

Unknown

RECRUITING

The Catholic University of Korea-St. Mary's Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Ahn-Gook Pharmaceuticals Co.,Ltd

INDUSTRY

NCT01413048 - Clinical Trial to Evaluate the Antihypertensive Effect of AGSCT101 in Patient With Hypertension | Biotech Hunter | Biotech Hunter